An edeine resistant mRNA-dependent protein synthesis system from a Saccharomyces cerevisiae mutant  by Herrera, Flor et al.
Volume 174, number 1 FEBS 1709 August 1984 
An edeine resistant mRNA-dependent protein synthesis system 
from a Saccharomyces cerevisiae mutant 
Flor Herrera, Nancy Moreno and Jose Antonio Martinez* 
Centro de Investigaciones Biomkdicas, Facultad de Ciencias de la Salud, Vniversidad e Carabobo, Carabobo and 
*Departamento deBiologia, Institute Pedagdgico de Maracay, Maracay, Venezuela 
Received 3 May 1984; revised version received 25 June 1984 
A cell-free protein synthesizing system from a mutant of Saccharomyces c revisiae translated exogenous 
mRNA in the presence of 2,uM edeine, while a similar system from wild-type strain was completely 
inhibited by the drug. The mutant ribosomes showed an affinity for [?]edeine comparable to the wild- 
type ribosomes, thereby suggesting that these macromolecules alone were not responsible for the edeine- 
resistant capacity of the mutant. 
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1. INTRODUCTION may impede the AUG recognition event [l 11. 
The yeast Saccharomyces cerevisiae, with its low 
genetic complexity and innumerable mutant 
availability, makes a convenient model for the 
study of mechanisms controlling gene expression 
in eukaryotes. The development of a yeast cell-free 
protein synthesizing system which translates ex- 
ogenous mRNA faithfully and efficiently [l-3] has 
provided the means for studying the mechanism 
and regulation of protein synthesis in this 
eukaryotic cell. In addition, cell-free systems from 
yeast mutants resistant o inhibitors of protein syn- 
thesis can be used as a tool for these analyses. 
From the above observations, it is possible to 
surmise that yeast mutant lysates resistant to 
edeine are systems which may permit analyses of 
various steps in peptide chain initiation. Here, we 
have identified a mutant of S. cerevisiae with a 
cell-free system capable of synthesizing protein in 
the presence of edeine. It is also shown that the 
mutant ribosomes alone are not responsible for 
this resistance. 
2. EXPERIMENTAL 
Antibiotics inhibiting specific steps in transla- 
tion have increased knowledge of this process. In 
particular, the basic oligopeptide, edeine has been 
shown to block initiation in lysates from pro- 
karyotic and eukaryotic organisms with no obser- 
vable effect on polypeptide elongation [4-81. 
While it has been suggested that edeine may pre- 
vent the union of the ribosomal subunits [6,8,9], it 
has also been reported to destabilize the GTP- 
dependent interaction of Met-tRNAi with 40 S 
subunits [lo]. Others have indicated that the drug 
2.1. Preparation of cell-free protein synthesizing 
systems (S-l 00 ‘) 
Strains of S. cerevisiae designated A364A (wild- 
type), El, E3, E5, E6, ElO, E28 and E54 (mutants 
of A364A resistant to edeine in vivo) were grown 
as in [12] and the S-100’ extract was prepared ac- 
cording to [l]. 
2.2. Assay for protein synthesis 
The assay was performed according to [2]. 
* All correspondence should be addressed to Apartado 
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2.3. Preparation of yeast mRNA 
Yeast mRNA was prepared following the pro- 
cedure in [13]. 
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2.4. [‘251]-labeling of edeine 
The antibiotic was iodinated as in [lo]. 
2.5. Binding of [12jI]edeine to ribosomes 
The final concentrations of all reaction com- 
ponents in a total volume of 150 ~1 were: 
OS-O.6 mg S-100’ extract from the mutant or 
wild-type strain, 20 mM Hepes-KOH buffer (pH 
7.4), 210 mM potassium acetate, 3mM 
magnesium acetate, 3 mM dithiothreitol, 0.5 mM 
ATP, 0.1 mM GTP, 20 mM creatine phosphate, 
10 pg creatine phosphokinase, lO(‘/o glycerol, and 
250 pmol [“‘I]edeine (80 cpm/pmol). Incubation 
was then carried out for 4 min at 20°C followed by 
cooling to 0°C and then these samples were layered 
onto 12 ml of IO-38% linear gradients of sucrose 
as in [3]. 
3. RESULTS AND DISCUSSION 
The effect of increasing concentrations of edeine 
on the translation of exogenous yeast mRNA in the 
wild-type lysate is shown in fig. 1. A concentration 
AIM EDEINE 
Fig.1. Effect of edeine on exogenous messenger 
translation in the whole wild-type lysate system. 
Incubations were carried out as described in the text. 
Edeine (Calbiochem Behring, La Jolla, CA) was added 
prior to the messenger. The results are expressed as 
percent activity obtained in the presence of edeine as 
compared to controls in the absence of the antibiotic. 
100% corresponded to 532 128 cpm. Data have been 
corrected for endogenous mRNA radioactivity 
incorporation by subtracting it (22320 cpm) from the 
[3H]leucine incorporated in the presence of exogenous 
Strain % activity 
A364A 3 
El 5 
E3 2 
ES 0 
E6 70 
El0 2 
El2 0 
E28 3 
E54 0 
Incubations were carried out as described in the text. 
Results are expressed as percent activity obtained in the 
presence of edeine as compared to controls in the 
absence of the antibiotic. Controls were similar in all 
cases, resulting in a mean value of 540500 cpm. Data 
have been corrected for endogenous mRNA 
radioactivity incorporation by substracting it from the 
[3H]leucine incorporated in the presence of exogenous 
mRNA. mRNA 
of 2.0&M completely inhibited the protein syn- 
thesizing activity of the wild-type cell-free system. 
Lysates of 8 S. cerevisiae mutants resistant to 
edeine in vivo were tested for their ability to syn- 
thesize protein in the presence of 2 FM edeine. The 
data presented in table 1 demonstrate that the in 
vitro protein synthesizing system from the mutant 
E6 was the only one capable of translating ex- 
ogenous mRNA in the presence of the drug while 
maintaining a 70% residual activity with respect o 
the control; a higher concentration of 3 PM was re- 
quired to produce 95% inhibition. The other 
mutants, as sensitive to edeine as the wild-type 
strain, may have changed membranes which, in 
turn, impeded the entry of the antibiotic into the 
cell. 
It has been shown that [“‘I]edeine is able to in- 
teract with 40 S subunits and 80 S ribosomes in 
reticulocyte lysates [lo]. To determine this interac- 
tion of the drug with both ribosome populations, 
the binding of [**‘I]edeine was tested in the wild- 
type and E6 extracts. Fig.2 shows that [‘*‘I]edeine 
was bound in both lysates to the 40 S and 80 S 
ribosomes in very similar proportions. 
The result indicates that the mutant ribosomes 
have an affinity for the drug comparable to that of 
Table 1 
Effect of 2 pM edeine on exogenous messenger 
translation in whole lysate systems 
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Fig.2. Binding of [*Z51]edeine to ribosomes from (A) wild-type extract and (B) mutant extract. Incubation components, 
centrifugation and analytical procedures are described in the text. 
the wild-type, suggesting that the ribosomes alone 
were not responsible for the capacity to resist the 
antibiotic effect as presented by the mutant. This 
ability probably involves other components of the 
protein synthesis initiation step. On the basis of 
these findings, the possibility of the mutant extract 
carrying an altered enzyme capable of degrading 
edeine thereby resulting in an extract resistant to 
the antibiotic was ruled out. 
Further investigations hould help define factors 
mediating the mutant resistance to edeine which, 
as a consequence, could contribute to the 
understanding of the yeast peptide initiation event. 
ACKNOWLEDGEMENTS 
We are indebted to Dr Calvin McLaughlin for 
kindly providing the mutants employed in this 
work. We thank Drs Juan P. Garcia Ballesta for 
many helpful discussions, Edgard Otaiza, Jose 
Perdomo and Ejidio Roman0 for allowing us to 
perform some of the experiments in their 
laboratories; Miss Aida Medina for her technical 
aid and Mrs Maria Suzzarini for expert secretarial 
assistance. This work was supported in part by 
grants from CONICIT (CICS-2 and CICS-6) and 
by CODECIH-Universidad de Carabobo. 
REFERENCES 
111 
PI 
131 
141 
PI 
161 
[71 
PI 
PI 
UOI 
[111 
WI 
v31 
Gasior, E., Herrera, F., Sadnik, I., McLaughlin, 
C. and Moldave, K. (1979) J. Biol. Chem. 254, 
3965-3969. 
Tuite, M., Plesset, J., Moldave, K. and 
McLaughlin, C. (1980) J. Biol. Chem. 255, 
8761-8766. 
Gasior, E., Herrera, F., McLaughlin, C.S. and 
Moldave, K. (1979) J. Biol. Chem. 254,3970-3976. 
Obrig, T., Irvin, J., Gulp, W. and Hardesty, B. 
(1971) Eur. J. Biochem. 21, 31-41. 
Kurylo-Borowska, Z. and Hierowski, M. (1975) 
B&him. Biophys. Acta 95, 590-597. 
Hunt, T. (1974)Ann. NY Acad. Sci. 241.223-231. 
Legon, S., Robertson, H.D. and Prensky, W. 
(1976) J. Mol. Biol. 106, 23-36. 
Kramer, G., Konecki, D., Cimadevilla, J.M. and 
Hardesty, B. (1976) Arch. Biochem. Biophys. 174, 
355-358. 
Hunter, A., Jackson, R. and Hunt, T. (1977) Eur. 
J. Biochem. 75, 159-170. 
Odom, O.W., Kramer, G., Henderson, A.B., 
Pinphanichakarm, P. and Hardesty, B. (1978) J. 
Biol. Chem. 253, 1807-1816. 
Kozak, M. and Shatkin, A.J. (1978) J. Biol. Chem. 
253, 6568-6577. 
Hartwell, L.H. (1967) J. Bacterial. 93, 1662-1670. 
Gallis, B.M., McDonnell, J.P., Hopper, J.E. and 
Young, E.T. (1975) Biochemistry 14, 1038-1046. 
49 
